Header Logo

Connection

MORVEN EDWARDS to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications MORVEN EDWARDS has written about Cost-Benefit Analysis.
MORVEN EDWARDS
Connection Strength
0.022
Cost-Benefit Analysis
  1. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? Vaccine. 2014 Aug 20; 32(37):4778-85.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.